IL17A and neoplasm: Our findings suggest that chemotherapy alone, when administered after surgical intervention in the adjuvant group, promotes a beneficial reduction in TNF-α, IL-17a and IL-10 levels, likely reflecting extensive tumor cell death induced by anticancer therapies and the consequent attenuation of inflammatory mechanisms [86,87].